Search

everythinglearnresearchcommunity

for

Search:↓

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Skin reactions from cancer treatments might predict how well the treatments work.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.